Scientific and Clinical Validation
- Dual CB1/CB2 receptor potent full agonist (learn more about CB1/CB2)
- Phase 1 study in subjects with lower back pain that were otherwise healthy demonstrated statistically significant increase in body weight versus drug exposure
- Phase 1b study completed
- Phase 2a study enrolling (CAReS Trial)
Learn more about our Cancer Appetite Recovery Study (CAReS) in cancer anorexia